TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
AXSM

Axsome Therapeutics Inc

Healthcare · Biotechnology

177.10$ -1.2% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AXSM
Line item 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.23 1.23 5.96 8.05 12.83
– 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.13 0.57 0.70 0.95
– 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 1.10 5.38 7.35 11.88
0.20 0.34 0.57 1.11 0.88 0.87 1.58 1.89 1.54 1.43 2.16 3.90 3.68
0.04 0.11 0.20 0.33 0.32 0.35 0.40 0.78 1.77 3.05 4.91 6.47 11.47
0.24 0.45 0.77 1.44 1.19 1.22 1.97 2.66 3.32 5.53 10.49 13.21 15.28
-0.24 -0.45 -0.77 -1.44 -1.19 -1.22 -1.98 -2.66 -3.32 -4.42 -5.10 -5.86 -3.40
0.04 0.18 0.08 0.01 0.06 0.04 0.04 0.07 0.15 0.18 0.14 0.14 0.13
-0.28 -0.47 -0.88 -1.42 -1.27 -1.15 -2.01 -2.77 -3.47 -4.60 -5.25 -5.99 -3.69
-0.24 -0.19 0.11 0.03 0.06 0.11 0.04 0.07 0.12 0.26 0.02 0.00 -0.01
-0.28 -0.47 -1.02 -1.42 -1.27 -1.15 -2.01 -2.77 -3.59 -4.60 -5.27 -5.99 -3.68
-0.24 -0.22 -0.77 -1.44 -1.22 -1.21 -1.98 -2.70 -3.28 -4.31 -4.95 -5.69 -3.38

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?